Tabuniag, Enorencio B.

HRN: 21-73-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2022
CEFUROXIME 1.5GM (VIAL)
08/19/2022
08/26/2022
IV
1.5gms
Q8
UTI

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines